Bharat Biotech submits 90% documents of Covaxin for WHO nod on emergency use

Bharat Biotech submits 90% documents of Covaxin for WHO nod on emergency use

The indegenous Coronavirus vaccine- Covaxin developed by Bharat Biotech, despite getting emergency approvals in India for, the vaccine has still not received emergency use authorization from the World Health Organization.
Check the source here –Source, Financial Express.
Change Language